{"version":"1.0","type":"link","title":"EVT-101 - Newikis","description":"EVT-101, also known as ENS-101, is an experimental medication which originated from Roche and is under development by Evotec AG for the treatment of major depressive disorder. It acts as a selective NMDA receptor subunit 2B (NR2B) antagonist. The drug was first claimed by Roche in 2002. By 2017,…","provider_name":"Newikis","provider_url":"https://newikis.com","cache_age":86400,"thumbnail_url":"https://thumb.wikimedia.org/wikipedia/commons/thumb/a/ad/EVT-101.svg/1280px-EVT-101.svg.png","thumbnail_width":1280,"thumbnail_height":549}